Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Montelukast Sodium Tablets

    Jump to

    • Ajanta Pharma launches generic asthma treatment tablets

    • Unichem Laboratories gets USFDA approval, up 4.5%

    • Glenmark slips 2% on recall of anti-asthma drug in US

      Glenmark Pharma shares declined more than 2 percent on Tuesday morning as the company's recall of its anti-asthma drug from the US market got the street nervous.

    • Dr Reddy launches Montelukast sodium tablets in US market

      Dr Reddy's Laboratories today announced that it has launched Montelukast sodium tablets and Montelukast sodium chewable tablets in US market on Monday.

    • Aurobindo gets USFDA nod for asthma drug

      Aurobindo Pharma today said it has received the final approval from USFDA to manufacture and market montelukast sodium tablets used for treating asthma and allergies.

    • Glenmark, Aurobindo get US nod for asthma treatment drug

      Glenmark Pharmaceuticals' US generics drugs subsidiary has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) to market Montelukast Sodium tablets in 10 mg strength, which are used for the treatment for prophylaxis and chronic treatment of asthma.

    • Glenmark gets tentative US FDA nod for asthma drug

      Glenmark Generics Inc USA has received tentative approval from US Food and Drugs Administration for Montelukast Sodium 10 mg tablets, a generic version of pharma major Merck's Singulair tablets.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347